Effekt og sikkerhed af Tarceva i kombination med gemcitabin som 1. linie behandling blev vurderet i et randomiseret, dobbeltblindt, placebokontrolleret studie hos patienter med lokalt fremskreden inoperabel eller metastaserende pancreas cancer.
The efficacy and safety of Tarceva in combination with gemcitabine as a first-line treatment was assessed in a randomised, double-blind, placebo-controlled trial in patients with locally advanced, unresectable or metastatic pancreatic cancer.